Linking chronic kidney disease and Parkinson’s disease: a literature review Jesús D. Meléndez-FloresIngrid Estrada-Bellmann Review Article 29 September 2020 Pages: 1 - 12
Current and emerging therapeutic targets for Parkinson’s disease Tanvi PingaleGirdhari Lal Gupta Review Article 22 October 2020 Pages: 13 - 27
Epilepsy in inherited neurotransmitter disorders: Spotlights on pathophysiology and clinical management Mario Mastrangelo Review Article 23 October 2020 Pages: 29 - 43
Crossing the blood-brain barrier with AAV vectors Dan LiuMingyang ZhuYong Diao Review Article 17 November 2020 Pages: 45 - 52
Advances in intervention methods and brain protection mechanisms of in situ and remote ischemic postconditioning Chun-Yan LiWei MaLi-Yan Li Review Article 12 October 2020 Pages: 53 - 65
Insulin resistance: a connecting link between Alzheimer’s disease and metabolic disorder Viplav KshirsagarChetan ThingoreArchana Juvekar Review Article 28 September 2020 Pages: 67 - 83
Physical exercise protocols in animal models of Alzheimer’s disease: a systematic review Ricardo Augusto Leoni De SousaCíntia Maria RodriguesRicardo Cardoso Cassilhas Review Article 23 October 2020 Pages: 85 - 95
Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: “Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats” by Ghosh et al., Metab Brain Dis 2020 July 21 Jan HomolakAna Babic PerhocMelita Salkovic-Petrisic Commentary 27 October 2020 Pages: 97 - 102
Circulating sortilin levels are associated with inflammation in patients with moyamoya disease Wenxiu HanYi QiaoPei Jiang Original Article 17 September 2020 Pages: 103 - 109
Skimmetin/osthole mitigates pain-depression dyad via inhibiting inflammatory and oxidative stress-mediated neurotransmitter dysregulation Lovedeep SinghAnudeep KaurRajbir Bhatti Original Article 01 September 2020 Pages: 111 - 121
LncRNA SNHG7 sponges miR-449a to promote pituitary adenomas progression Xiongfei YueCe DongBaogen Pan Original Article 03 September 2020 Pages: 123 - 132
Laterality and sex differences in the expression of brain-derived neurotrophic factor in developing rat hippocampus Reza SardarZahra ZandiehJavad Hami Original Article Open access 25 September 2020 Pages: 133 - 144
Mood disorders are associated with the reduction of brain derived neurotrophic factor in the hypocampus in rats submitted to the hipercaloric diet Rafael Tamborena MalheirosHelena Oliveira DelgadoMorgana Duarte da Silva Original Article 06 October 2020 Pages: 145 - 151
Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis Michelle S. AntunesFernando Vagner Lobo LaddLeandro Cattelan Souza Original Article 15 October 2020 Pages: 153 - 167
Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates Rana Fadhil MousaHussein Kadhem Al-HakeimMichael Maes Original Article 23 September 2020 Pages: 169 - 183
The metabolic effect of α-ketoisocaproic acid: in vivo and in vitro studies Hémelin R. FariasJoice R. GabrielEmilio L. Streck Original Article 09 October 2020 Pages: 185 - 192
Acute and chronic lithium treatment increases Wnt/β-catenin transcripts in cortical and hippocampal tissue at therapeutic concentrations in mice Vanessa J. De-PaulaCarla Cristine C. dos SantosEdecio Cunha-Neto Short Communication 10 November 2020 Pages: 193 - 197